×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ACXP – acurx pharmaceuticals, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ACXP
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/20
07:06 am
acxp
Acurx Board of Directors Approves Bitcoin as Treasury Reserve Asset [Yahoo! Finance]
High
Report
Acurx Board of Directors Approves Bitcoin as Treasury Reserve Asset [Yahoo! Finance]
11/20
07:01 am
acxp
Acurx Board of Directors Approves Bitcoin as Treasury Reserve Asset
High
Report
Acurx Board of Directors Approves Bitcoin as Treasury Reserve Asset
11/20
07:01 am
acxp
Acurx Board of Directors Approves Bitcoin as Treasury Reserve Asset
High
Report
Acurx Board of Directors Approves Bitcoin as Treasury Reserve Asset
11/20
07:01 am
acxp
Acurx Board of Directors Approves Bitcoin as Treasury Reserve Asset
High
Report
Acurx Board of Directors Approves Bitcoin as Treasury Reserve Asset
11/18
07:12 am
acxp
Acurx Sponsored and Participated in the Peggy Lillis Foundation Inaugural CDI Scientific Symposium and Presented Ibezapolstat Ph2b Clinical Data Update [Yahoo! Finance]
Low
Report
Acurx Sponsored and Participated in the Peggy Lillis Foundation Inaugural CDI Scientific Symposium and Presented Ibezapolstat Ph2b Clinical Data Update [Yahoo! Finance]
11/18
07:00 am
acxp
Acurx Sponsored and Participated in the Peggy Lillis Foundation Inaugural CDI Scientific Symposium and Presented Ibezapolstat Ph2b Clinical Data Update
Low
Report
Acurx Sponsored and Participated in the Peggy Lillis Foundation Inaugural CDI Scientific Symposium and Presented Ibezapolstat Ph2b Clinical Data Update
11/14
08:15 am
acxp
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
Medium
Report
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
11/14
02:21 am
acxp
Acurx Pharmaceuticals Inc (ACXP) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ... [Yahoo! Finance]
Medium
Report
Acurx Pharmaceuticals Inc (ACXP) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ... [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
11/13/2024
07:00 am
acxp
acurx pharmaceuticals, inc.
BEAT
Report
-3.2%
acurx pharmaceuticals, inc.
8/9/2024
07:01 am
acxp
acurx pharmaceuticals, inc.
BEAT
Report
-8.7%
acurx pharmaceuticals, inc.
5/15/2024
07:00 am
acxp
acurx pharmaceuticals, inc.
MISS
Report
7.7%
acurx pharmaceuticals, inc.
3/18/2024
07:01 am
acxp
acurx pharmaceuticals, inc.
MISS
Report
-13.7%
acurx pharmaceuticals, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: